Search
Patexia Research
Case number 2021-2342

Par Pharmaceutical, Inc. v. Eagle Pharmaceuticals, Inc. > Documents

Date Field Doc. No.Description (Pages)
Aug 21, 2022 0 PAR PHARMACEUTICAL, INC. v. EAGLE PHARMACEUTICALS, INC. [OPINION] [precedential] (0)
Aug 18, 2022 48 JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [867157] [MVH] [Entered: 08/18/2022 09:59 AM] (1)
Aug 18, 2022 47 OPINION filed for the court by Moore, Chief Judge; Prost, Circuit Judge and Hughes, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [867156] [MVH] [Entered: 08/18/2022 09:55 AM] (9)
Jul 7, 2022 46 Notice from Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC Notice of Withdrawal of Blake Greene as Counsel. Service: 07/07/2022 by email. [859721] [21-2342] [Blake Greene] [Entered: 07/07/2022 03:21 PM] (2)
Jul 7, 2022 45 Submitted after ORAL ARGUMENT to Panel: Moore, Chief Judge; Prost, Circuit Judge and Hughes, Circuit Judge.Arguing counsel: Martin Jay Black for Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC and John C. O'Quinn for Eagle Pharmaceuticals, Inc..Oral Argument Audio available here. [859694] [MJL] [Entered: 07/07/2022 03:06 PM] (0)
Jun 6, 2022 44 Letter from Appellee Eagle Pharmaceuticals, Inc. re: July 7 oral arguments in nos. 21-2275 and 21-2342. Service: 06/06/2022 by email. [853767] [21-2342] [John O'Quinn] [Entered: 06/06/2022 01:48 PM] (2)
Jun 3, 2022 43 Response to notice of oral argument from Appellee Eagle Pharmaceuticals, Inc.. Service: 06/03/2022 by email. [853589] [21-2342] [John O'Quinn] [Entered: 06/03/2022 08:02 PM] (3)
Jun 2, 2022 42 Notice from Appellee Eagle Pharmaceuticals, Inc. withdrawal of M. Lembo. Service: 06/02/2022 by email. [853317] [21-2342] [William Burgess] [Entered: 06/02/2022 04:50 PM] (1)
Jun 2, 2022 41 Certification of Compliance with Revised Protocols for In-Person Arguments for Appellants Par Pharmaceutical, Inc., Endo Par Innovation Company, LLC and Par Sterile Products, LLC. Service: 06/02/2022 by email. [853208] [21-2342] [Martin Black] [Entered: 06/02/2022 10:47 AM] (2)
Jun 2, 2022 40 Response to notice of oral argument from Appellants Par Pharmaceutical, Inc., Endo Par Innovation Company, LLC and Par Sterile Products, LLC. Service: 06/02/2022 by email. [853203] [21-2342] [Martin Black] [Entered: 06/02/2022 10:44 AM] (1)
May 20, 2022 39 NOTICE OF ORAL ARGUMENT. Panel: 2207E. Case scheduled July 7, 2022. Response to Notice of Oral Argument due: 06/03/2022. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [850930] [MJL] [Entered: 05/20/2022 11:04 AM] (2)
Apr 28, 2022 38 The following additional conflict dates submitted by Bryan Scott Hales for Eagle Pharmaceuticals, Inc. have been accepted by the court: 07/05/2022, 07/06/2022. [846044] [MJL] [Entered: 04/28/2022 01:22 PM] (0)
Apr 27, 2022 37 Notice from Appellee Eagle Pharmaceuticals, Inc. regarding conflicts with oral argument. Service: 04/27/2022 by email. [845873] [21-2342] [Bryan Hales] [Entered: 04/27/2022 09:55 PM] (2)
Mar 10, 2022 36 The following conflict dates submitted by Martin Jay Black for Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC have been accepted by the court: 06/06/2022, 06/07/2022, 06/08/2022, 06/09/2022, 06/10/2022, 10/05/2022. [836073] [MJL] [Entered: 03/10/2022 11:56 AM] (0)
Mar 9, 2022 35 The following conflict dates submitted by Bryan Scott Hales for Eagle Pharmaceuticals, Inc. have been accepted by the court: 06/07/2022, 06/08/2022, 06/09/2022. [835867] [MJL] [Entered: 03/09/2022 03:18 PM] (0)
Mar 8, 2022 34 Notice from Appellee Eagle Pharmaceuticals, Inc. regarding conflicts with oral argument. Service: 03/08/2022 by email. [835568] [21-2342] [Bryan Hales] [Entered: 03/08/2022 05:01 PM] (3)
Mar 8, 2022 33 Notice from Appellants Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC regarding conflicts with oral argument. Service: 03/08/2022 by email. [835561] [21-2342] [Martin Black] [Entered: 03/08/2022 04:51 PM] (2)
Mar 4, 2022 31 6 paper copies of Doc. No. [27], [23], [15] received from Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. [834955] [VDW] [Entered: 03/04/2022 01:30 PM] (0)
Mar 3, 2022 32 6 paper copies of Doc. No. [22] received from Appellee Eagle Pharmaceuticals, Inc.. [834958] [VDW] [Entered: 03/04/2022 01:33 PM] (0)
Mar 1, 2022 25 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellee Eagle Pharmaceuticals, Inc. and Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. Service: 03/01/2022 by email. [834172] [21-2342] [Martin Black] [Entered: 03/01/2022 03:55 PM] (2)
Mar 1, 2022 24 Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. Service: 03/01/2022 by email. [834170] [21-2342] [Martin Black] [Entered: 03/01/2022 03:53 PM] (2)
Mar 1, 2022 26 MODIFIED ENTRY: APPENDIX FILED by Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. Service: 03/01/2022 by email. [834174] --[Edited 03/01/2022 by JCW -compliance review complete] [Martin Black] [Entered: 03/01/2022 03:59 PM] (724)
Mar 1, 2022 27 MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. Service: 03/01/2022 by email. [834175]--[Edited 03/01/2022 by JCW - compliance review complete] [Martin Black] [Entered: 03/01/2022 04:02 PM] (0)
Mar 1, 2022 28 Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [834182] [JCW] [Entered: 03/01/2022 04:13 PM] (0)
Mar 1, 2022 29 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [834183] [JCW] [Entered: 03/01/2022 04:14 PM] (1)
Mar 1, 2022 30 Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellee Eagle Pharmaceuticals, Inc.. Service: 03/01/2022 by email. [834205] [21-2342] [Bryan Hales] [Entered: 03/01/2022 08:25 PM] (2)
Feb 22, 2022 23 MODIFIED ENTRY: REPLY BRIEF FILED by Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. Service: 02/22/2022 by email. [832607] --[Edited 02/22/2022 by JCW - compliance review complete] [Martin Black] [Entered: 02/22/2022 01:05 PM] (38)
Feb 1, 2022 21 Amended Certificate of Interest for Appellee Eagle Pharmaceuticals, Inc.. Service: 02/01/2022 by email. [828463] [21-2342] [Bryan Hales] [Entered: 02/01/2022 07:30 PM] (3)
Feb 1, 2022 22 MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellee Eagle Pharmaceuticals, Inc.. Service: 02/01/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [828464] --[Edited 02/02/2022 by JCW - compliance review complete] [Bryan Hales] [Entered: 02/01/2022 07:35 PM] (85)
Jan 27, 2022 20 Entry of appearance for Benjamin A. Lasky; William H. Burgess as counsel for Appellee Eagle Pharmaceuticals, Inc.. Service: 01/27/2022 by email. [827339] [21-2342] [Bryan Hales] [Entered: 01/27/2022 11:10 AM] (2)
Jan 3, 2022 19 **TEXT ONLY** ORDER granting motion to extend time to file brief [18] filed by Appellee Eagle Pharmaceuticals, Inc. The response brief is due 02/01/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [822385] [JCW] [Entered: 01/03/2022 05:17 PM] (0)
Dec 30, 2021 18 MOTION of Appellee Eagle Pharmaceuticals, Inc. to extend the time to 02/01/2022 to file brief. Service: 12/30/2021 by email. [822123] [21-2342] [Bryan Hales] [Entered: 12/30/2021 10:08 PM] (4)
Dec 6, 2021 17 REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [816524] [JCW] [Entered: 12/06/2021 03:47 PM] (0)
Dec 6, 2021 15 MODIFIED ENTRY: OPENING BRIEF FILED by Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. Service: 12/06/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [816495] --[Edited 12/06/2021 by JCW - compliance review complete] [Martin Black] [Entered: 12/06/2021 03:21 PM] (270)
Nov 10, 2021 14 **TEXT ONLY** ORDER granting motion to extend time to file brief [13] filed by Appellants Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC. The opening brief is due 12/06/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [811632] [JCW] [Entered: 11/10/2021 03:56 PM] (0)
Nov 10, 2021 13 MOTION of Appellants Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC to extend the time to 12/06/2021 to file brief. Service: 11/10/2021 by email. [811627] [21-2342] [Martin Black] [Entered: 11/10/2021 03:47 PM] (7)
Oct 11, 2021 12 Docketing Statement for the Appellee Eagle Pharmaceuticals, Inc.. Service: 10/11/2021 by email. [804758] [21-2342] [Bryan Hales] [Entered: 10/11/2021 11:23 PM] (2)
Oct 11, 2021 11 Corrected Entry of appearance for Bryan S. Hales; Jeanna M. Wacker; John C. O'Quinn; Matthew A. Lembo as counsel for Appellee Eagle Pharmaceuticals, Inc.. Service: 10/11/2021 by email. [804757] [21-2342] [Bryan Hales] [Entered: 10/11/2021 11:17 PM] (2)
Oct 8, 2021 10 NOTICE OF NON-COMPLIANCE: The submission of Appellee Eagle Pharmaceuticals, Inc., Entry of Appearance [8], is not in compliance with the rules of this court (see attached). Compliant document due on 10/18/2021. Service as of this date by the Clerk of Court. [804507] [JCW] [Entered: 10/08/2021 09:53 AM] (1)
Oct 7, 2021 9 Certificate of Interest for Appellee Eagle Pharmaceuticals, Inc.. Service: 10/07/2021 by email. [804453] [21-2342] [Bryan Hales] [Entered: 10/07/2021 06:55 PM] (3)
Oct 7, 2021 8 Entry of appearance for Bryan S. Hales; Jeanna M. Wacker; John C. O'Quinn; Matthew A. Lembo as counsel for Appellee Eagle Pharmaceuticals, Inc.. Service: 10/07/2021 by email. [804452] [21-2342] This document is non-compliant. See Doc No.[10] [Bryan Hales] [Entered: 10/07/2021 06:49 PM] (2)
Sep 30, 2021 7 Docketing Statement for the Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. Service: 09/30/2021 by email. [802930] [21-2342] [Martin Black] [Entered: 09/30/2021 04:25 PM] (2)
Sep 30, 2021 6 Transcript Purchase Order Form for the Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC indicating that a transcript is already on file. Service: 09/30/2021 by email. [802929] [21-2342] [Martin Black] [Entered: 09/30/2021 04:24 PM] (1)
Sep 30, 2021 5 Amended Entry of appearance for Martin J. Black; Robert D. Rhoad; Jonathan D. Loeb; Blake B. Greene; Sharon K. Gagliardi; Luke M. Reilly; Daniel R. Roberts; Brian M. Goldberg as counsel for Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. Service: 09/30/2021 by email. [802925] [21-2342] [Martin Black] [Entered: 09/30/2021 04:20 PM] (3)
Sep 30, 2021 4 NOTICE OF NON-COMPLIANCE: The submission of Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC, Entry of Appearance [3], is not in compliance with the rules of this court (see attached). Compliant document due on 10/07/2021. Service as of this date by the Clerk of Court. [802798] [JCW] [Entered: 09/30/2021 10:25 AM] (1)
Sep 29, 2021 3 Entry of appearance for Martin J. Black; Robert D. Rhoad; Jonathan D. Loeb; Blake B. Greene; Sharon K. Gagliardi; Luke M. Reilly; Daniel R. Roberts; Brian M. Goldberg as counsel for Appellants Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc. and Par Sterile Products, LLC. Service: 09/29/2021 by email. [802630] [21-2342] This document is non-compliant. See Doc No.[4] [Martin Black] [Entered: 09/29/2021 03:17 PM] (3)
Sep 29, 2021 2 Certificate of Interest for Appellants Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC. Service: 09/29/2021 by email. [802625] [21-2342] [Martin Black] [Entered: 09/29/2021 03:13 PM] (3)
Sep 23, 2021 1 Appeal docketed. Received: 09/23/2021. [801302]Entry of Appearance is due on 10/07/2021. Certificate of Interest is due on 10/07/2021. Docketing Statement is due on 10/07/2021. Appellants' brief is due on 11/22/2021. [JCW] [Entered: 09/23/2021 10:59 AM] (75)
Menu